BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2904527)

  • 1. Xamoterol: stabilising the cardiac beta receptor?
    Lancet; 1988 Dec; 2(8625):1401-2. PubMed ID: 2904527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of xamoterol in moderate cardiac insufficiency].
    Kayanakis JG; Larouchi L; Doat P; Grenet B; Fauvel JM; Bounhoure JP
    Presse Med; 1989 Apr; 18(13):667-70. PubMed ID: 2566161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.
    Cheron P; Nannan M; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():46-7. PubMed ID: 1971589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xamoterol, a beta1-adrenoceptor partial agonist: a new approach to heart failure. Proceedings of the 1st International Heart Failure. Interlaken, 1988.
    Barnett DB; Breckenridge A
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):1S-91S. PubMed ID: 2572249
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
    Hadfield SE; Slee SJ; Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
    Limas CJ; Limas C
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
    Barnett DB; Lu XY
    Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study.
    Tangø M; Lyngborg K; Mehlsen J; Svendsen TL; Trap-Jensen J
    Int J Cardiol; 1992 Jan; 34(1):63-8. PubMed ID: 1347763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
    Sato H; Matsuyama T; Ozaki H; Fukushima M; Matsumoto M
    Kokyu To Junkan; 1984 Nov; 32(11):1159-62. PubMed ID: 6151727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
    Richaud M; Lechat P; Komajda M; Landault C; Fournier P; Fraysse JB; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Feb; 83(2):247-52. PubMed ID: 1968739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of xamoterol in failing human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Eur Heart J; 1990 Apr; 11(4):323-7. PubMed ID: 1970536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H; Hanet C; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol.
    Mehlsen J; Trap-Jensen J
    Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Xamoterol].
    Volpi A; Maggioni AP
    Medicina (Firenze); 1988; 8(4):473-5. PubMed ID: 2907597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.